|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 238.93 USD | +1.33% |
|
-2.74% | -5.29% |
| Jan. 09 | UBS Adjusts Price Target on Gartner to $270 From $256, Maintains Neutral Rating | MT |
| Dec. 17 | Morgan Stanley Adjusts Price Target on Gartner to $275 From $281, Maintains Equalweight Rating | MT |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 4.28 | 8.23 | 9.87 | 9.34 | 8.91 | |||||
Return on Total Capital | 7.61 | 15.71 | 20.57 | 19.81 | 18.21 | |||||
Return On Equity % | 26.29 | 108.6 | 269.78 | 194.28 | 122.93 | |||||
Return on Common Equity | 26.29 | 108.6 | 269.78 | 194.28 | 122.93 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 67.19 | 69.5 | 69.07 | 67.78 | 67.72 | |||||
SG&A Margin | 49.76 | 44.51 | 44.34 | 45.4 | 45.88 | |||||
EBITDA Margin % | 16.73 | 24.25 | 24.01 | 21.57 | 20.88 | |||||
EBITA Margin % | 15.14 | 22.81 | 23.02 | 20.71 | 20.05 | |||||
EBIT Margin % | 12.09 | 20.5 | 21.22 | 19.14 | 18.61 | |||||
Income From Continuing Operations Margin % | 6.51 | 16.76 | 14.75 | 14.94 | 20 | |||||
Net Income Margin % | 6.51 | 16.76 | 14.75 | 14.94 | 20 | |||||
Net Avail. For Common Margin % | 6.51 | 16.76 | 14.75 | 14.94 | 20 | |||||
Normalized Net Income Margin | 5.75 | 11.53 | 12.44 | 10.99 | 10.96 | |||||
Levered Free Cash Flow Margin | 18.02 | 21.13 | 15.88 | 17.05 | 15.18 | |||||
Unlevered Free Cash Flow Margin | 19.58 | 22.34 | 16.64 | 18.33 | 16.37 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.57 | 0.64 | 0.74 | 0.78 | 0.77 | |||||
Fixed Assets Turnover | 4.04 | 5.24 | 7.19 | 8.88 | 11.09 | |||||
Receivables Turnover (Average Receivables) | 3.15 | 3.58 | 3.7 | 3.68 | 3.73 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 0.79 | 0.78 | 0.77 | 0.91 | 1.06 | |||||
Quick Ratio | 0.67 | 0.63 | 0.63 | 0.78 | 0.92 | |||||
Operating Cash Flow to Current Liabilities | 0.31 | 0.39 | 0.31 | 0.31 | 0.37 | |||||
Days Sales Outstanding (Average Receivables) | 116.21 | 101.82 | 98.76 | 99.11 | 98.03 | |||||
Average Days Payable Outstanding | 9.74 | 11.1 | 14.28 | 14.03 | 10.76 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 270.73 | 890.43 | 1.39K | 451.08 | 213.37 | |||||
Total Debt / Total Capital | 73.03 | 89.9 | 93.27 | 81.85 | 68.09 | |||||
LT Debt/Equity | 257.95 | 858.77 | 1.34K | 435.2 | 205.99 | |||||
Long-Term Debt / Total Capital | 69.58 | 86.71 | 90.1 | 78.97 | 65.73 | |||||
Total Liabilities / Total Assets | 85.1 | 95 | 96.88 | 91.31 | 84.07 | |||||
EBIT / Interest Expense | 4.29 | 9.87 | 15.73 | 8.78 | 9.18 | |||||
EBITDA / Interest Expense | 6.96 | 12.75 | 18.95 | 10.52 | 10.9 | |||||
(EBITDA - Capex) / Interest Expense | 6.24 | 12.14 | 17.49 | 9.72 | 10.1 | |||||
Total Debt / EBITDA | 3.67 | 2.64 | 2.25 | 2.26 | 2.09 | |||||
Net Debt / EBITDA | 2.78 | 2.03 | 1.75 | 1.29 | 0.7 | |||||
Total Debt / (EBITDA - Capex) | 4.09 | 2.77 | 2.44 | 2.45 | 2.26 | |||||
Net Debt / (EBITDA - Capex) | 3.1 | 2.13 | 1.9 | 1.39 | 0.75 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -3.44 | 15.48 | 15.67 | 7.87 | 6.1 | |||||
Gross Profit, 1 Yr. Growth % | 2.21 | 19.44 | 14.96 | 5.86 | 6.01 | |||||
EBITDA, 1 Yr. Growth % | 20.16 | 67.4 | 14.5 | -3.07 | 2.72 | |||||
EBITA, 1 Yr. Growth % | 22.04 | 73.94 | 16.75 | -2.96 | 2.74 | |||||
EBIT, 1 Yr. Growth % | 30.81 | 95.72 | 19.78 | -2.69 | 3.16 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 14.34 | 197.5 | 1.79 | 9.24 | 42.07 | |||||
Net Income, 1 Yr. Growth % | 14.34 | 197.5 | 1.79 | 9.24 | 42.07 | |||||
Normalized Net Income, 1 Yr. Growth % | 35.62 | 131.46 | 24.86 | -4.74 | 5.84 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 15.62 | 211.15 | 8.14 | 11.24 | 44.4 | |||||
Accounts Receivable, 1 Yr. Growth % | -6.78 | 10.29 | 13.91 | 3.3 | 5.97 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -6.06 | -16.49 | -14.68 | -10.22 | -20.51 | |||||
Total Assets, 1 Yr. Growth % | 2.3 | 1.37 | -1.57 | 7.35 | 8.92 | |||||
Tangible Book Value, 1 Yr. Growth % | -8.96 | 23.76 | -0.23 | -16.08 | -28.2 | |||||
Common Equity, 1 Yr. Growth % | 16.18 | -65.97 | -38.61 | 198.79 | 99.69 | |||||
Cash From Operations, 1 Yr. Growth % | 59.75 | 45.3 | -16.08 | 4.93 | 28.48 | |||||
Capital Expenditures, 1 Yr. Growth % | -43.71 | -28.67 | 80.58 | -4.56 | -1.34 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 78.8 | 35.13 | -13.05 | 15.79 | -5.54 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 70.42 | 31.75 | -13.82 | 18.82 | -5.24 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 1.55 | 5.6 | 15.58 | 11.7 | 6.98 | |||||
Gross Profit, 2 Yr. CAGR % | 4.82 | 10.49 | 17.18 | 10.32 | 5.94 | |||||
EBITDA, 2 Yr. CAGR % | 6.15 | 41.82 | 38.44 | 5.35 | -0.22 | |||||
EBITA, 2 Yr. CAGR % | 5.93 | 45.7 | 42.5 | 6.44 | -0.15 | |||||
EBIT, 2 Yr. CAGR % | 16.35 | 60 | 53.11 | 7.96 | 0.19 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 47.59 | 84.43 | 74.02 | 5.45 | 24.58 | |||||
Net Income, 2 Yr. CAGR % | 47.59 | 84.43 | 74.02 | 5.45 | 24.58 | |||||
Normalized Net Income, 2 Yr. CAGR % | 24.63 | 77.17 | 70 | 9.06 | 0.41 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 49.18 | 89.67 | 83.44 | 9.68 | 26.74 | |||||
Accounts Receivable, 2 Yr. CAGR % | -0.99 | 1.4 | 12.09 | 8.48 | 4.62 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 91.74 | -11.42 | -15.59 | -12.48 | -15.52 | |||||
Total Assets, 2 Yr. CAGR % | 8.61 | 1.84 | -0.11 | 2.79 | 8.13 | |||||
Tangible Book Value, 2 Yr. CAGR % | -7.55 | 6.15 | 11.12 | -8.5 | -22.37 | |||||
Common Equity, 2 Yr. CAGR % | 13.21 | -37.12 | -54.29 | 35.44 | 144.27 | |||||
Cash From Operations, 2 Yr. CAGR % | 38.46 | 52.35 | 10.42 | -6.16 | 16.11 | |||||
Capital Expenditures, 2 Yr. CAGR % | -18.69 | -36.63 | 13.49 | 31.28 | -2.97 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -1.73 | 55.58 | 8.5 | 0.34 | 6.6 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -1.69 | 49.84 | 6.55 | 1.19 | 6.11 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 7.37 | 5.99 | 8.85 | 12.95 | 9.8 | |||||
Gross Profit, 3 Yr. CAGR % | 11.42 | 9.49 | 11.96 | 13.28 | 8.86 | |||||
EBITDA, 3 Yr. CAGR % | 21.58 | 23.56 | 32.06 | 22.93 | 4.47 | |||||
EBITA, 3 Yr. CAGR % | 23.74 | 24.97 | 35.33 | 25.37 | 5.19 | |||||
EBIT, 3 Yr. CAGR % | 48.5 | 38.37 | 45.28 | 31.64 | 6.34 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 333.3 | 86.44 | 51.29 | 49 | 16.47 | |||||
Net Income, 3 Yr. CAGR % | 333.3 | 86.44 | 51.29 | 49 | 16.47 | |||||
Normalized Net Income, 3 Yr. CAGR % | 130.93 | 53.19 | 57.67 | 40.16 | 7.98 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 330.63 | 90.61 | 57.28 | 55.27 | 20.21 | |||||
Accounts Receivable, 3 Yr. CAGR % | 1.43 | 2.64 | 5.41 | 9.08 | 7.63 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 64.39 | 45.34 | -12.52 | -13.83 | -15.24 | |||||
Total Assets, 3 Yr. CAGR % | 0.15 | 6.14 | 0.69 | 2.32 | 4.79 | |||||
Tangible Book Value, 3 Yr. CAGR % | -6.87 | 1.89 | 3.98 | 1.19 | -15.6 | |||||
Common Equity, 3 Yr. CAGR % | 3.5 | -24.16 | -37.62 | -14.54 | 54.15 | |||||
Cash From Operations, 3 Yr. CAGR % | 52.53 | 40.7 | 24.89 | 8.56 | 4.2 | |||||
Capital Expenditures, 3 Yr. CAGR % | -8.85 | -22.16 | -10.16 | 7.12 | 19.36 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 119.44 | 9.34 | 28.15 | 10.87 | -1.66 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 81.24 | 8.39 | 24.61 | 10.5 | -1 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 13.64 | 14.13 | 10.58 | 8.24 | 8.1 | |||||
Gross Profit, 5 Yr. CAGR % | 15.78 | 17.03 | 13.69 | 9.82 | 9.51 | |||||
EBITDA, 5 Yr. CAGR % | 14.2 | 23.42 | 28.06 | 15.93 | 18.06 | |||||
EBITA, 5 Yr. CAGR % | 13.64 | 23.72 | 30.93 | 17.2 | 19.83 | |||||
EBIT, 5 Yr. CAGR % | 9.55 | 22.78 | 50.33 | 25.3 | 25.22 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 8.72 | 32.6 | 200.82 | 48.44 | 39.98 | |||||
Net Income, 5 Yr. CAGR % | 8.72 | 32.6 | 200.82 | 48.44 | 39.98 | |||||
Normalized Net Income, 5 Yr. CAGR % | 4.8 | 21.59 | 104.3 | 33.73 | 31.63 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 7.52 | 31.86 | 206.1 | 52.8 | 44.27 | |||||
Accounts Receivable, 5 Yr. CAGR % | 16.68 | 16.59 | 5.57 | 4.93 | 5.09 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 55.36 | 46.54 | 25.92 | 18.65 | -13.74 | |||||
Total Assets, 5 Yr. CAGR % | 27.53 | 25.66 | 0.05 | 4.79 | 3.6 | |||||
Tangible Book Value, 5 Yr. CAGR % | 23.03 | 34.29 | -0.05 | -2.4 | -7.5 | |||||
Common Equity, 5 Yr. CAGR % | 52.46 | 43.55 | -25.36 | -4.36 | 7.69 | |||||
Cash From Operations, 5 Yr. CAGR % | 21.19 | 29.12 | 34.04 | 19.66 | 21.3 | |||||
Capital Expenditures, 5 Yr. CAGR % | 12.71 | 3.71 | -0.5 | -4.06 | -7.35 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 20.78 | 27 | 65.56 | 5.65 | 18.15 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 21.75 | 27.25 | 46.55 | 5.45 | 16.85 |
- Stock Market
- Equities
- IT Stock
- Financials Gartner, Inc.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















